The binding sites for cocaine and dopamine in the dopamine transporter overlap
about
Modafinil as a catecholaminergic agent: empirical evidence and unanswered questionsMechanisms of dopamine transporter regulation in normal and disease statesX-ray structure of dopamine transporter elucidates antidepressant mechanismR-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuseThe novel triple reuptake inhibitor JZAD-IV-22 exhibits an antidepressant pharmacological profile without locomotor stimulant or sensitization propertiesInsights to ligand binding to the monoamine transporters-from homology modeling to LeuBAT and dDATDesigning modulators of monoamine transporters using virtual screening techniquesNonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substratesHow LeuT shapes our understanding of the mechanisms of sodium-coupled neurotransmitter transportersSpontaneous inward opening of the dopamine transporter is triggered by PIP2-regulated dynamics of the N-terminusNeurotransmitter and psychostimulant recognition by the dopamine transporter.Cocaine inhibits dopamine D2 receptor signaling via sigma-1-D2 receptor heteromersModeling and dynamics of the inward-facing state of a Na+/Cl- dependent neurotransmitter transporter homologueStructures of LeuT in bicelles define conformation and substrate binding in a membrane-like contextThe atypical stimulant and nootropic modafinil interacts with the dopamine transporter in a different manner than classical cocaine-like inhibitorsModeling of pharmacokinetics of cocaine in human reveals the feasibility for development of enzyme therapies for drugs of abuseLigand induced conformational changes of the human serotonin transporter revealed by molecular dynamics simulationsFrom linked open data to molecular interaction: studying selectivity trends for ligands of the human serotonin and dopamine transporterA conserved salt bridge between transmembrane segments 1 and 10 constitutes an extracellular gate in the dopamine transporterClassic Studies on the Interaction of Cocaine and the Dopamine TransporterInsights from molecular dynamics: the binding site of cocaine in the dopamine transporter and permeation pathways of substrates in the leucine and dopamine transporters.Missense dopamine transporter mutations associate with adult parkinsonism and ADHD.Modelling and mutational analysis of Aspergillus nidulans UreA, a member of the subfamily of urea/H⁺ transporters in fungi and plantsReceptor-Based Discovery of a Plasmalemmal Monoamine Transporter Inhibitor via High Throughput Docking and Pharmacophore Modeling.Ligand effects on cross-linking support a conformational mechanism for serotonin transport.Binding and orientation of tricyclic antidepressants within the central substrate site of the human serotonin transporter.De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorderMolecular modeling and ligand docking for solute carrier (SLC) transportersConformational changes in dopamine transporter intracellular regions upon cocaine binding and dopamine translocationPIP2 regulates psychostimulant behaviors through its interaction with a membrane protein.Transmembrane domain 6 of the human serotonin transporter contributes to an aqueously accessible binding pocket for serotonin and the psychostimulant 3,4-methylene dioxymethamphetamine.Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter.The substrate-driven transition to an inward-facing conformation in the functional mechanism of the dopamine transporter.Structural analysis of the extracellular entrance to the serotonin transporter permeation pathway.Comparison of human solute carriersTargeting of dopamine transporter to filopodia requires an outward-facing conformation of the transporter.SLC6 family transporter SNF-10 is required for protease-mediated activation of sperm motility in C. elegansUnbiased simulations reveal the inward-facing conformation of the human serotonin transporter and Na(+) ion release.Structure-activity relationships for a novel series of citalopram (1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile) analogues at monoamine transportersSyntaxin 1A regulates dopamine transporter activity, phosphorylation and surface expression.
P2860
Q21129426-E9E38D9F-EB46-496E-BAD1-34EEE3C6E332Q24598750-01C5239D-701E-4A5A-ADED-B8386FF4FA1AQ24612997-621BEE3D-B308-442C-BF13-7D2A3AD52834Q24621917-E1D5C22E-EDBA-4801-99DB-BE534FA3D242Q24633511-1B78D74A-F3B2-4DB2-9D4A-1B8D39D24B17Q26781554-36C5B6E1-5BF3-4679-8842-2E2CF33D1839Q26781605-2B528037-EC4A-4EC3-81B5-1078F6C4927EQ26853319-448785A4-F563-48CA-BBC3-A53F6253C26BQ26866308-59ED4BFB-9EB9-476E-BAD1-778D79374E9EQ27300323-90BE3F82-AAEC-49AD-9270-F00BC8D65624Q27316816-0CD9BE16-2F72-4D49-8D16-C47961CD9540Q27325489-4F65DC07-279D-4401-B493-1473AA788F8AQ27334606-DE5282E8-EF7B-4A67-9DFC-B01BAA2D04ACQ27676749-21D6961A-74B0-4CAE-B9DF-D955B8CCA82DQ28477546-9A155AF3-02BC-42AB-AF98-5A55DE8049DBQ28481567-AAE678C3-1032-4208-B1F0-87F3A53DEBFFQ28533835-321FC99F-801E-4655-AE51-9BADF4B63A8EQ28596136-B6104CF6-DADB-4CD6-B6FB-E72D1551E5C3Q30368030-9F73AFBB-8E89-4287-89A2-260299D2ED2BQ30397145-4A2D7E11-96B2-4CAD-9C3F-01F663EF3774Q30532521-D1A6BC3A-5691-4682-99DA-DF8A665FE032Q30581669-E9B33F70-927F-4F7E-86E1-5C0ECEB1F92DQ30582173-41CF48C2-E327-415B-B5A9-D647461B4C3FQ33547418-BA8EA355-D159-4706-8BD2-D48BE5DA4723Q33553309-993A4659-C835-48EF-B132-E7213C969063Q33707171-9E8CD9BA-D439-41A0-9EC8-5A8F81246003Q33715513-D379B137-0C25-4FDC-9089-CCB08F7F6C1AQ33751096-4BE051B9-9C47-4ED6-9BB7-596C45FAC4C7Q33758304-DBE87CB0-5B3B-42FA-A1BB-B92B45681FA3Q33773594-478EDB29-D4C4-48CE-86C5-B4990F7FB60FQ33799683-EE77185F-7172-477D-96EF-589F63CD1756Q33808035-9A2BDB76-C0B6-4AAA-A7A2-14C09630BF11Q33813126-88493E09-E6C5-4F42-B714-4476A449C532Q33832622-D6026016-7868-4A31-8F40-4E8A6AF4745FQ33836276-5E4F0940-8927-497B-AB24-C46B0258862EQ33905523-BF81A636-806D-43E2-9D50-8FE5D22B7CAEQ34052546-97C7BD6A-4D3F-417B-9B28-BCAA7CA9A70CQ34064167-36866599-F385-4656-A8B0-EC370F908F80Q34102188-691D1BD1-750D-4C52-B4A8-924689D305B8Q34103973-203C95B8-DB73-4308-9178-62C0DC61DEB8
P2860
The binding sites for cocaine and dopamine in the dopamine transporter overlap
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
The binding sites for cocaine and dopamine in the dopamine transporter overlap
@ast
The binding sites for cocaine and dopamine in the dopamine transporter overlap
@en
The binding sites for cocaine and dopamine in the dopamine transporter overlap
@nl
type
label
The binding sites for cocaine and dopamine in the dopamine transporter overlap
@ast
The binding sites for cocaine and dopamine in the dopamine transporter overlap
@en
The binding sites for cocaine and dopamine in the dopamine transporter overlap
@nl
prefLabel
The binding sites for cocaine and dopamine in the dopamine transporter overlap
@ast
The binding sites for cocaine and dopamine in the dopamine transporter overlap
@en
The binding sites for cocaine and dopamine in the dopamine transporter overlap
@nl
P2093
P2860
P3181
P356
P1433
P1476
The binding sites for cocaine and dopamine in the dopamine transporter overlap
@en
P2093
Claus J Loland
Harel Weinstein
Jonathan A Javitch
Julie Kniazeff
Klaudia Raniszewska
Luis Gracia
Marianne L Bergmann
Thijs Beuming
Ulrik Gether
P2860
P2888
P3181
P356
10.1038/NN.2146
P407
P577
2008-07-01T00:00:00Z
P5875
P6179
1032831529